Folger Nolan Fleming Douglas Capital Management, Inc Pfizer Inc Transaction History

Folger Nolan Fleming Douglas Capital Management, Inc

$839 Million
Q2 2025

A detailed history of Folger Nolan Fleming Douglas Capital Management, Inc transactions in Pfizer Inc stock. As of the latest transaction made, Folger Nolan Fleming Douglas Capital Management, Inc holds 17,188 shares of PFE stock, worth $422,481. This represents 0.05% of its overall portfolio holdings.

Number of Shares

17,188

Previous 21,875 21.43%

Holding current value

$422,481

Previous $554,000 24.91%

% of portfolio

0.05%

Previous 0.07%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	SELL	$21.59 - $24.84 $101,192 - $116,425	-4,687 Reduced 21.43%	17,188 $416,000
Q1 2025 Apr 16, 2025	SELL	$25.01 - $27.13 $37,965 - $41,183	-1,518 Reduced 6.49%	21,875 $554,000
Q4 2024 Jan 15, 2025	SELL	$24.8 - $30.19 $59,619 - $72,576	-2,404 Reduced 9.32%	23,393 $620,000
Q3 2024 Oct 25, 2024	SELL	$27.7 - $31.39 $45,815 - $51,919	-1,654 Reduced 6.03%	25,797 $746,000
Q2 2024 Jul 09, 2024	SELL	$25.26 - $29.6 $23,314 - $27,320	-923 Reduced 3.25%	27,451 $768,000
Q1 2024 Apr 12, 2024	SELL	$25.89 - $29.73 $44,712 - $51,343	-1,727 Reduced 5.74%	28,374 $787,000
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $73,791 - $95,846	-2,824 Reduced 8.58%	30,101 $866,000
Q3 2023 Oct 25, 2023	SELL	$32.09 - $37.51 $46,562 - $54,427	-1,451 Reduced 4.22%	32,925 $1.09 Million
Q2 2023 Jul 27, 2023	SELL	$36.12 - $41.79 $53,565 - $61,974	-1,483 Reduced 4.14%	34,376 $1.26 Million
Q1 2023 Apr 28, 2023	SELL	$39.39 - $51.28 $128,923 - $167,839	-3,273 Reduced 8.36%	35,859 $1.46 Million
Q4 2022 Jan 30, 2023	BUY	$41.75 - $54.5 $367,775 - $480,090	8,809 Added 29.05%	39,132 $2.01 Million
Q3 2022 Nov 01, 2022	BUY	$43.76 - $53.42 $103,273 - $126,071	2,360 Added 8.44%	30,323 $1.33 Million
Q2 2022 Jul 15, 2022	SELL	$46.53 - $55.17 $50,252 - $59,583	-1,080 Reduced 3.72%	27,963 $1.47 Million
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $39,207 - $48,583	-857 Reduced 2.87%	29,043 $1.5 Million
Q4 2021 Feb 01, 2022	SELL	$41.32 - $61.25 $92,763 - $137,506	-2,245 Reduced 6.98%	29,900 $1.77 Million
Q3 2021 Oct 29, 2021	SELL	$39.25 - $50.42 $5,887 - $7,563	-150 Reduced 0.46%	32,145 $1.38 Million
Q2 2021 Aug 09, 2021	SELL	$35.91 - $40.68 $62,986 - $71,352	-1,754 Reduced 5.15%	32,295 $1.27 Million
Q1 2021 May 11, 2021	SELL	$33.49 - $37.77 $108,842 - $122,752	-3,250 Reduced 8.71%	34,049 $1.23 Million
Q4 2020 Feb 05, 2021	BUY	$33.47 - $42.56 $11,848 - $15,066	354 Added 0.96%	37,299 $1.37 Million
Q2 2020 Aug 05, 2020	SELL	$30.12 - $36.54 $16,084 - $19,512	-534 Reduced 1.42%	36,945 $1.21 Million
Q1 2020 May 06, 2020	SELL	$27.03 - $38.62 $1,162 - $1,660	-43 Reduced 0.11%	37,479 $1.22 Million
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $8,999 - $11,670	277 Added 0.74%	37,522 $1.35 Million
Q2 2019 Aug 09, 2019	SELL	$36.98 - $41.52 $7,395 - $8,304	-200 Reduced 0.53%	37,245 $1.61 Million
Q1 2019 May 07, 2019	SELL	$37.5 - $41.2 $7,500 - $8,240	-200 Reduced 0.53%	37,445 $1.59 Million
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $1.38 Million - $1.58 Million	36,002 Added 2191.24%	37,645 $1.64 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $1.39 Million - $1.59 Million	-36,252 Reduced 95.66%	1,643 $1.64 Million
Q3 2018 Nov 07, 2018	SELL	$34.47 - $41.81 $19,303 - $23,413	-560 Reduced 1.46%	37,895 $1.67 Million
Q2 2018 Aug 08, 2018	SELL	$32.98 - $35.16 $6,101 - $6,504	-185 Reduced 0.48%	38,455 $1.4 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $63,094 - $66,945	1,897 Added 5.16%	38,640 $1.4 Million
Q3 2017 Nov 09, 2017	SELL	$31.0 - $34.15 $29,481 - $32,476	-951 Reduced 2.52%	36,743 $1.31 Million
Q2 2017 Aug 11, 2017	BUY	N/A	37,694	37,694 $1.27 Million

Others Institutions Holding PFE

# of Institutions

3,330

Shares Held

3.61B

Call Options Held

104M

Put Options Held

129M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Folger Nolan Fleming Douglas Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Folger Nolan Fleming Douglas Capital Management, Inc with notifications on news.

Account

Folger Nolan Fleming Douglas Capital Management, Inc Pfizer Inc Transaction History